Pathogen: clinical or host-associated sample from ... - BioSample

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Pathogen: clinical or host-associated sample from Enterobacter hormaechei

Identifiers: BioSample: SAMN36727338; Sample name: BWH_388_E_clo; SRA: SRS18432648

Organism: Enterobacter hormaechei
cellular organisms; Bacteria; Pseudomonadati; Pseudomonadota; Gammaproteobacteria; Enterobacterales; Enterobacteriaceae; Enterobacter; Enterobacter cloacae complex

Package: Pathogen: clinical or host-associated; version 1.0

Attributes

isolate	BWH_388_E_clo
collected by	Brigham and Women's Hospital
collection date	2022
geographic location	USA:Boston
host	Homo sapiens
host disease	Wound infection
isolation source	Chest wall wound
latitude and longitude	42.3362 N 71.1067 W
host age	35

BioProject: PRJNA278886
Retrieve all samples from this project

Submission: Brigham and Women's Hospital, Jay Worley; 2023-07-27

Antibiogram
Antibiotic	Resistance phenotype	Measurement sign	Measurement	Measurement units	Laboratory typing method	Laboratory typing platform	Vendor	Laboratory typing method version or reagent	Testing standard
amikacin	susceptible	<=	2	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
amoxicillin-clavulanic acid	resistant	>=	32/16	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ampicillin	susceptible	<=	2	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
cefepime	susceptible	==	2.0	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
cefoxitin	resistant	>=	64	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ceftazidime	resistant	>=	64	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ceftriaxone	resistant	>=	64	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ciprofloxacin	susceptible	<=	0.25	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
doxycycline	intermediate	==	8.0	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
ertapenem	susceptible	<=	0.5	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
erythromycin	intermediate	==	1.0	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
gentamicin	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
levofloxacin	intermediate	==	1.0	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
linezolid	susceptible	==	2.0	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
meropenem	susceptible	<=	0.25	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
piperacillin-tazobactam	resistant	>=	128/4	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
streptomycin	susceptible	<=	1000	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
tetracycline	susceptible	==	2.0	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
tobramycin	susceptible	<=	1	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
trimethoprim-sulfamethoxazole	susceptible	<=	1/19	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI
vancomycin	susceptible	==	2.0	mg/L	MIC	Vitek	Biomérieux	96-Well Plate	CLSI